|
| August
4, 2026 |
| Regional
intelligence on Drugs, Diagnostics,
Devices & Digital Health |
|
|
|
* may need subscription to view |
|
BIG4BIO
CEO WEEKLY Q&A:
Todd Dickinson, President & CEO,
Stellaromics |
| In this
Q&A, Dickinson explains why
conventional spatial platforms lose
critical biological information by cutting
tissue too thin, how its Pyxa® platform
preserves native tissue architecture in
sections up to 100 microns thick, and what
that means for drug discovery, tumor
biology, and patient care. More |
|
|
- ICYMI: Altimmune Initiates PERFORMA Phase 3
Trial of Pemvidutide in Patients With MASH
More
- ICYMI: We The Billions Launches Personalized
Cognitive Care Focused on How Each Brain Works
More
|
|
|
|
- GeneDx: Second Quarter 2026 Financial
Results More
- Medifast: Second Quarter 2026 Financial
Results More
- More on Rockville’s Supernus More
Than Tripling Size Through Merger of Equals
More*
More*
More*
More
|
|
- Big4Bio CEO Weekly Q&A: Todd
Dickinson, President & CEO, Stellaromics
More
- Biotech Hangout: Episode 191
Podcast
- Slone Partners: Premier Executive
Search and Talent Advisory Firm More
- Subscribe to LifeSci Startup for
Updates on US Startups More
|
|
- Danaher: Appoints Julie Sawyer
Montgomery as President and Chief Executive
Officer More
- OPPORTUNITY: Chief Scientific Officer,
Manassas, VA
More
- OPPORTUNITY: President, PA More
- OPPORTUNITY: Vice President, Global BD,
Remote More
- Slone Partners: Places Amer Mirza, PhD, as
Chief Scientific Officer at Prolynx More
- Slone Partners: The Convergence of
MedTech and Digital Health - How New Hybrid
Devices Are Reshaping Care Delivery and
Leadership Profiles More
|
|
|
DISCOVER COMPANIES |
|
Big4Bio: Capital Region Life
Science Company Directory |
|
Locate a specific company or
explore new companies in life
science. |
|
Explore
our Company Directory
|
Provided courtesy
of
|
|
|
|
|
|
|
|
You are
receiving this email because
you signed up for one of our
newsletters at Big4Bio.com,
signed up at one of our
partner or sponsor events,
or given as a gift
subscription by your firm or
organization. Unsubscribe
Big4Bio:Capital
Region, all rights reserved
2026
© 2026
Big4Bio, a division of
BigBio Communications. All
rights reserved.
|
|
|
|
|